Filing Details
- Accession Number:
- 0001225208-14-025461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-18 16:17:11
- Reporting Period:
- 2014-12-17
- Filing Date:
- 2014-12-18
- Accepted Time:
- 2014-12-18 16:17:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595013 | G Patricia Christian | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Vp -Quality, Reg & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-12-17 | 140 | $167.42 | 12,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-17 | 188 | $168.48 | 12,196 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $167.41 to $167.43. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $168.42 to $168.54. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Billionaire Hedge Funds
